Cargando…
Oral corticoid, aspirin, anticoagulant, colchicine, and furosemide to improve the outcome of hospitalized COVID-19 patients - the COCAA-COLA cohort study
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The British Infection Association. Published by Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7871882/ https://www.ncbi.nlm.nih.gov/pubmed/33577902 http://dx.doi.org/10.1016/j.jinf.2021.02.008 |
_version_ | 1783649100469633024 |
---|---|
author | Kevorkian, Jean-Philippe Lopes, Amanda Sène, Damien Riveline, Jean-Pierre Vandiedonck, Claire Féron, Florine Nassarmadji, Kladoum Mouly, Stéphane Mauvais-Jarvis, Franck Gautier, Jean-François Mégarbane, Bruno |
author_facet | Kevorkian, Jean-Philippe Lopes, Amanda Sène, Damien Riveline, Jean-Pierre Vandiedonck, Claire Féron, Florine Nassarmadji, Kladoum Mouly, Stéphane Mauvais-Jarvis, Franck Gautier, Jean-François Mégarbane, Bruno |
author_sort | Kevorkian, Jean-Philippe |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7871882 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | The British Infection Association. Published by Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-78718822021-02-10 Oral corticoid, aspirin, anticoagulant, colchicine, and furosemide to improve the outcome of hospitalized COVID-19 patients - the COCAA-COLA cohort study Kevorkian, Jean-Philippe Lopes, Amanda Sène, Damien Riveline, Jean-Pierre Vandiedonck, Claire Féron, Florine Nassarmadji, Kladoum Mouly, Stéphane Mauvais-Jarvis, Franck Gautier, Jean-François Mégarbane, Bruno J Infect Letter to the Editor The British Infection Association. Published by Elsevier Ltd. 2021-06 2021-02-09 /pmc/articles/PMC7871882/ /pubmed/33577902 http://dx.doi.org/10.1016/j.jinf.2021.02.008 Text en © 2021 The British Infection Association. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Letter to the Editor Kevorkian, Jean-Philippe Lopes, Amanda Sène, Damien Riveline, Jean-Pierre Vandiedonck, Claire Féron, Florine Nassarmadji, Kladoum Mouly, Stéphane Mauvais-Jarvis, Franck Gautier, Jean-François Mégarbane, Bruno Oral corticoid, aspirin, anticoagulant, colchicine, and furosemide to improve the outcome of hospitalized COVID-19 patients - the COCAA-COLA cohort study |
title | Oral corticoid, aspirin, anticoagulant, colchicine, and furosemide to improve the outcome of hospitalized COVID-19 patients - the COCAA-COLA cohort study |
title_full | Oral corticoid, aspirin, anticoagulant, colchicine, and furosemide to improve the outcome of hospitalized COVID-19 patients - the COCAA-COLA cohort study |
title_fullStr | Oral corticoid, aspirin, anticoagulant, colchicine, and furosemide to improve the outcome of hospitalized COVID-19 patients - the COCAA-COLA cohort study |
title_full_unstemmed | Oral corticoid, aspirin, anticoagulant, colchicine, and furosemide to improve the outcome of hospitalized COVID-19 patients - the COCAA-COLA cohort study |
title_short | Oral corticoid, aspirin, anticoagulant, colchicine, and furosemide to improve the outcome of hospitalized COVID-19 patients - the COCAA-COLA cohort study |
title_sort | oral corticoid, aspirin, anticoagulant, colchicine, and furosemide to improve the outcome of hospitalized covid-19 patients - the cocaa-cola cohort study |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7871882/ https://www.ncbi.nlm.nih.gov/pubmed/33577902 http://dx.doi.org/10.1016/j.jinf.2021.02.008 |
work_keys_str_mv | AT kevorkianjeanphilippe oralcorticoidaspirinanticoagulantcolchicineandfurosemidetoimprovetheoutcomeofhospitalizedcovid19patientsthecocaacolacohortstudy AT lopesamanda oralcorticoidaspirinanticoagulantcolchicineandfurosemidetoimprovetheoutcomeofhospitalizedcovid19patientsthecocaacolacohortstudy AT senedamien oralcorticoidaspirinanticoagulantcolchicineandfurosemidetoimprovetheoutcomeofhospitalizedcovid19patientsthecocaacolacohortstudy AT rivelinejeanpierre oralcorticoidaspirinanticoagulantcolchicineandfurosemidetoimprovetheoutcomeofhospitalizedcovid19patientsthecocaacolacohortstudy AT vandiedonckclaire oralcorticoidaspirinanticoagulantcolchicineandfurosemidetoimprovetheoutcomeofhospitalizedcovid19patientsthecocaacolacohortstudy AT feronflorine oralcorticoidaspirinanticoagulantcolchicineandfurosemidetoimprovetheoutcomeofhospitalizedcovid19patientsthecocaacolacohortstudy AT nassarmadjikladoum oralcorticoidaspirinanticoagulantcolchicineandfurosemidetoimprovetheoutcomeofhospitalizedcovid19patientsthecocaacolacohortstudy AT moulystephane oralcorticoidaspirinanticoagulantcolchicineandfurosemidetoimprovetheoutcomeofhospitalizedcovid19patientsthecocaacolacohortstudy AT mauvaisjarvisfranck oralcorticoidaspirinanticoagulantcolchicineandfurosemidetoimprovetheoutcomeofhospitalizedcovid19patientsthecocaacolacohortstudy AT gautierjeanfrancois oralcorticoidaspirinanticoagulantcolchicineandfurosemidetoimprovetheoutcomeofhospitalizedcovid19patientsthecocaacolacohortstudy AT megarbanebruno oralcorticoidaspirinanticoagulantcolchicineandfurosemidetoimprovetheoutcomeofhospitalizedcovid19patientsthecocaacolacohortstudy |